Skip to main content
OpenTrials

Clinical trial condition

Prurigo

Explore clinical trials studying Prurigo. Study availability and eligibility vary by location and protocol.

7 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Prurigo trial results

Completed

A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN)

NCT05764161

Conditions
Dermatitis, Prurigo, Prurigo Nodularis, +2 more
Locations
  • University of Alabama At Birmingham Birmingham, Alabama, United States
  • Northwest Arkansas Clinical Trials Center Arkansas City, Arkansas, United States
  • Dermatology Research Associates Los Angeles, California, United States
  • Clinical Science Institute Clinical Research Specialists Inc Santa Monica, California, United States
View all 76 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN)

NCT05755438

Conditions
Dermatitis, Prurigo, Skin Diseases, +1 more
Locations
  • Medical Dermatology Specialists Phoenix Phoenix, Arizona, United States
  • Johnson Dermatology Fort Smith, Arkansas, United States
  • First Oc Dermatology Fountain Valley, California, United States
  • Dermatology Associates Pc Rockville, Maryland, United States
View all 71 locations
View Trial Details
Completed

Study of Nalbuphine HCl ER Tablets in Patients With Prurigo Nodularis

NCT02174419

Conditions
Nodularis Prurigo, Pathological Conditions, Signs and Symptoms, Prurigo, +6 more
Locations
  • Case Western Reserve University Cleveland, Ohio, United States
  • Temple University Hospital Philadelphia, Pennsylvania, United States
  • University of Münster Münster, Germany
  • Samodzielny Publiczny Szpital Kliniczny Nr 1 we Wroclawiu Wroclaw, Lower Silesian Voivodeship, Poland
View Trial Details
Completed

A Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

NCT04501679

Conditions
Dermatitis, Neurodermatitis, Pathological Conditions, Signs and Symptoms, +8 more
Locations
  • Galderma Investigational Site Fountain Valley, California, United States
  • Galderma Investigational Site San Diego, California, United States
  • Galderma Investigational Site Washington D.C., District of Columbia, United States
  • Galderma Investigational Site Aventura, Florida, United States
View all 74 locations
View Trial Details
Completed

Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

NCT04501666

Conditions
Dermatitis, Neurodermatitis, Pathological Conditions, Signs and Symptoms, +8 more
Locations
  • Galderma Investigational Site Birmingham, Alabama, United States
  • Galderma Investigational Site Birmingham, Alabama, United States
  • Galderma Investigational Site Los Angeles, California, United States
  • Galderma Investigational Site Sacramento, California, United States
View all 100 locations
View Trial Details

Related conditions